CDX-3379 exerts potent antitumor activity in PIK3CA wild type HNSCC cells in vivo (Fig. 4a, b and Supplementary Fig. 6), similar to that previously reported in multiple HPV− and HPV+HNSCC cells20,27,28. Here, PIK3CA is linked to head and neck squamous cell carcinoma.